Current Medical Research and Opinion
Dapagliflozin and ventricular repolarization across heart failure phenotypes
Cohort study of 700 peopleInterventions
3 months
- Dapagliflozin
- SLC5A2
- Heart failure
- Heart failure with preserved ejection fraction
- Heart failure with reduced ejection fraction
- Humans
The paper
Mersin Üniversitesi; State Hospital
Current Medical Research and Opinion, 7 Oct 2026


